Integra LifeSciences Holdings Corporation (IART) Balance Sheet
As of 2026-09-30 (10-Q), Integra LifeSciences Holdings Corporation (IART) reported total assets of $3.5B, total liabilities of $2.4B and shareholders' equity of $1.1B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $252.3M. Long-term debt: $697.5M.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
IARTIntegra LifeSciences Holdings CorporationFollow IART — free
—
Price chart with a free account
- Market cap
- 926.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 24 Feb, in 123 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.13 | 0.10 | 0.10 | 0.12 | 0.07 | 0.05 | 0.10 | 0.17 | 0.14 | 0.20 | 0.47 | 0.51 | 0.46 | 0.28 | 0.25 | 0.24 | 0.25 | |
| Short-term investments | — | — | — | — | — | — | 0.00 | — | — | — | — | — | 0.00 | 0.03 | 0.03 | 0.03 | 0.06 | |
| Receivables | 0.11 | 0.12 | 0.11 | 0.12 | 0.11 | 0.13 | 0.15 | 0.25 | 0.27 | 0.28 | 0.23 | 0.23 | 0.26 | 0.26 | 0.27 | 0.28 | 0.25 | |
| Inventory | 0.15 | 0.17 | 0.17 | 0.21 | 0.19 | 0.21 | 0.22 | 0.30 | 0.28 | 0.32 | 0.31 | 0.32 | 0.32 | 0.39 | 0.43 | 0.49 | 0.46 | |
| Current assets | 0.44 | 0.45 | 0.45 | 0.52 | 0.53 | 0.44 | 0.50 | 0.82 | 0.78 | 0.86 | 1.24 | 1.15 | 1.16 | 1.06 | 1.08 | 1.16 | 1.19 | |
| Total assets | 1.02 | 1.14 | 1.16 | 1.19 | 1.59 | 1.77 | 1.81 | 3.21 | 3.11 | 3.30 | 3.62 | 3.78 | 3.89 | 3.78 | 4.04 | 3.60 | 3.51 | |
| Current liabilities | 0.20 | 0.10 | 0.11 | 0.12 | 0.13 | 0.14 | 0.12 | 0.35 | 0.26 | 0.33 | 0.40 | 0.34 | 0.32 | 0.31 | 0.92 | 0.46 | 0.33 | |
| Long-term debt | — | — | — | — | — | — | — | — | 0.90 | 0.88 | 0.88 | 0.84 | 0.78 | 0.78 | 0.76 | 0.73 | 0.70 | |
| Total liabilities | 0.52 | 0.65 | 0.65 | 0.53 | 0.88 | 1.02 | 0.97 | 2.25 | 1.73 | 1.89 | 2.10 | 2.10 | 2.09 | 2.19 | 2.49 | 2.56 | 2.44 | |
| Shareholders' equity | 0.50 | 0.49 | 0.52 | 0.67 | 0.70 | 0.75 | 0.84 | 0.96 | 1.38 | 1.42 | 1.51 | 1.68 | 1.80 | 1.59 | 1.55 | 1.04 | 1.07 |
USD billions · SEC XBRL
Integra LifeSciences Holdings Corporation — questions
- How much cash does Integra LifeSciences Holdings Corporation have?
- $252.3M in cash and cash equivalents as of 2026-09-30.
- How much debt does Integra LifeSciences Holdings Corporation have?
- $697.5M of long-term debt as of 2026-09-30.
- What are Integra LifeSciences Holdings Corporation's total assets?
- $3.5B as of 2026-09-30.
- What is Integra LifeSciences Holdings Corporation's shareholders' equity?
- $1.1B as of 2026-09-30.
Every figure on this page comes from Integra LifeSciences Holdings Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.